PDX Core
PDX Core
批准号:
10732949
负责人:
Michael T. Lewis
金额:
$19.79万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-09-25 至 2028-06-30
关键词:
AnimalsBioinformaticsBreastBreast Cancer therapyCharacteristicsCollaborationsCollectionCommunitiesCore FacilityDataData AnalysesData CommonsData DisplayDevelopmentDrug resistanceGoalsGrantGrowth and Development functionHumanInfrastructureInstitutionJointsLogisticsMaintenanceMalignant NeoplasmsMedicineModelingModificationMolecularMusOrganPatientsPharmaceutical PreparationsPharmacotherapyPilot ProjectsPopulation HeterogeneityProceduresQuality ControlReproducibilityResearchResearch InstituteResearch Project GrantsResourcesSamplingSiteTestingTexasTherapeuticTissue Sampleanticancer researchcancer preventioncancer subtypescollegecost effectivedata exchangeethnic diversityin vivo Modelindividual patientmalignant breast neoplasmpathogenpatient derived xenograft modelpreclinical trialprogramsracial diversityrefractory cancerrepositoryresponsestandard of caresuccesstechnology developmenttreatment responsetumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PDX CORE PROJECT SUMMARY
The goals of the PDTC PDX Core are to establish and maintain PDX lines for the purpose of conducting animal
preclinical trials using experimental and standard-of-care therapeutics; to promote quality control, reproducibility,
and collaboration by developing and maintaining shared Standard Operating Procedures (SOPs) for PDX
development, maintenance, experimentation, and pathogen testing; to provide infrastructure to manage large PDX
collections and to generate, store, and manage PDX-based experimental data generated by the projects; to
facilitate exchange of PDX models between the PDXNet program; and to facilitate transfer of experimental data
to the PDTC Bioinformatics Core and the PDTC PDXNet Data Commons and Coordinating Center to relate
treatment responses to the molecular characteristics of individual patients’ tumors. Our PDTC PDX Core current
comprises 262 breast PDX lines available for projects within our PDTC Center and across the PDXNet program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core-001
-
批准号:10710331
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2022
-
负责人:Michael T. Lewis
-
依托单位:
Core-001
-
批准号:10710333
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2022
-
负责人:Michael T. Lewis
-
依托单位:
INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER
-
批准号:10688170
-
项目类别:
-
资助金额:$62.02万
-
财政年份:2019
-
负责人:Michael T. Lewis
-
依托单位:
INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER
-
批准号:10241425
-
项目类别:
-
资助金额:$63.29万
-
财政年份:2019
-
负责人:Michael T. Lewis
-
依托单位:
INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER
-
批准号:10020941
-
项目类别:
-
资助金额:$63.29万
-
财政年份:2019
-
负责人:Michael T. Lewis
-
依托单位:
INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER
-
批准号:10478972
-
项目类别:
-
资助金额:$62.02万
-
财政年份:2019
-
负责人:Michael T. Lewis
-
依托单位:
Multi-omic, Exposure-informed, Genealogical Approach (mErGE)
-
批准号:10370622
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
PDX Trial Center for Breast Cancer Therapy
-
批准号:9446429
-
项目类别:
-
资助金额:$248.22万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
Research Project 2: Targetin Tumor-Initiating Cell (TIC) Heterogeneity To Overcome Chemotherapy Resistance
-
批准号:10681678
-
项目类别:
-
资助金额:$22.4万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
Targeting mitochondrial dependencies in chemo resistant triple negative breast cancer
-
批准号:10581266
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
PDX Trial Center for Breast Cancer Therapy
-
批准号:10732947
-
项目类别:
-
资助金额:$118.71万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
Research Project 2: Targetin Tumor-Initiating Cell (TIC) Heterogeneity To Overcome Chemotherapy Resistance
-
批准号:9446435
-
项目类别:
-
资助金额:$95.03万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
PDX Trial Center for Breast Cancer Therapy
-
批准号:9985272
-
项目类别:
-
资助金额:$124.07万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
PDX Trial Center for Breast Cancer Therapy
-
批准号:10223224
-
项目类别:
-
资助金额:$124.06万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
Tolinapant efficacy in a subset of triple negative breast cancers
-
批准号:10581272
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
Research Project 1: Enhancing neoadjuvant therapy to prevent breast cancer recurrence
-
批准号:10732951
-
项目类别:
-
资助金额:$19.79万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
PDX Trial Center for Breast Cancer Therapy
-
批准号:10005183
-
项目类别:
-
资助金额:$124.07万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
Research Project 2: Targetin Tumor-Initiating Cell (TIC) Heterogeneity To Overcome Chemotherapy Resistance
-
批准号:10223230
-
项目类别:
-
资助金额:$46.71万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
PDX Trial Center for Breast Cancer Therapy
-
批准号:10681672
-
项目类别:
-
资助金额:$52.08万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
PDX Trial Center for Breast Cancer Therapy
-
批准号:10200553
-
项目类别:
-
资助金额:$12.0万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
海外基金